摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(3-bromophenoxy)pyridazine | 40890-12-8

中文名称
——
中文别名
——
英文名称
3-(3-bromophenoxy)pyridazine
英文别名
3-m-Bromphenoxypyridazin
3-(3-bromophenoxy)pyridazine化学式
CAS
40890-12-8
化学式
C10H7BrN2O
mdl
——
分子量
251.082
InChiKey
LQIQAUAOIRPNCV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    14
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    35
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    3-(3-bromophenoxy)pyridazineN-溴代丁二酰亚胺(NBS)四(三苯基膦)钯 、 sodium azide 、 溶剂黄146 作用下, 以 1,4-二氧六环N,N-二甲基甲酰胺甲苯 为溶剂, 反应 34.0h, 生成 2-azido-1-[3-(pyridazin-3-yloxy)phenyl]ethan-1-ol
    参考文献:
    名称:
    2-PHENYLMORPHOLINE AND 2-PHENYL(THIO)MORPHOLINE COMPOUNDS AND USES THEREOF
    摘要:
    Provided herein is a compound of Structural Formula I: or a pharmaceutically acceptable salt thereof, wherein values for the variables (e.g., X, Y, R1, R2, R3, R4, m, n, o) are as disclosed herein. Also provided herein are pharmaceutical compositions comprising a compound of Structural Formula I, or a pharmaceutically acceptable salt thereof, and methods of using the compounds, pharmaceutically acceptable salts thereof and pharmaceutical compositions of the foregoing,e.g., to treat a neurological or psychiatric disease or disorder, or a metabolic disease, disorder or condition.
    公开号:
    WO2024118488A1
  • 作为产物:
    描述:
    参考文献:
    名称:
    2-PHENYLMORPHOLINE AND 2-PHENYL(THIO)MORPHOLINE COMPOUNDS AND USES THEREOF
    摘要:
    Provided herein is a compound of Structural Formula I: or a pharmaceutically acceptable salt thereof, wherein values for the variables (e.g., X, Y, R1, R2, R3, R4, m, n, o) are as disclosed herein. Also provided herein are pharmaceutical compositions comprising a compound of Structural Formula I, or a pharmaceutically acceptable salt thereof, and methods of using the compounds, pharmaceutically acceptable salts thereof and pharmaceutical compositions of the foregoing,e.g., to treat a neurological or psychiatric disease or disorder, or a metabolic disease, disorder or condition.
    公开号:
    WO2024118488A1
点击查看最新优质反应信息